GR3033199T3 - Method for preparing n, n'-disubstitued cyclic ureas - Google Patents
Method for preparing n, n'-disubstitued cyclic ureasInfo
- Publication number
- GR3033199T3 GR3033199T3 GR20000400893T GR20000400893T GR3033199T3 GR 3033199 T3 GR3033199 T3 GR 3033199T3 GR 20000400893 T GR20000400893 T GR 20000400893T GR 20000400893 T GR20000400893 T GR 20000400893T GR 3033199 T3 GR3033199 T3 GR 3033199T3
- Authority
- GR
- Greece
- Prior art keywords
- disubstitued
- preparing
- cyclic ureas
- ureas
- cyclic
- Prior art date
Links
- 235000013877 carbamide Nutrition 0.000 title 1
- -1 cyclic ureas Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
- C07D243/04—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
- C07D317/14—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D317/28—Radicals substituted by nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D323/00—Heterocyclic compounds containing more than two oxygen atoms as the only ring hetero atoms
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/469,409 US5532356A (en) | 1995-06-06 | 1995-06-06 | Method for preparing N,N'-disubstituted cyclic ureas |
PCT/US1996/008556 WO1996039393A1 (en) | 1995-06-06 | 1996-06-04 | Method for preparing n, n'-disubstitued cyclic ureas |
Publications (1)
Publication Number | Publication Date |
---|---|
GR3033199T3 true GR3033199T3 (en) | 2000-08-31 |
Family
ID=23863677
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GR20000400893T GR3033199T3 (en) | 1995-06-06 | 2000-04-12 | Method for preparing n, n'-disubstitued cyclic ureas |
Country Status (20)
Country | Link |
---|---|
US (1) | US5532356A (el) |
EP (1) | EP0830349B1 (el) |
JP (1) | JPH11506765A (el) |
AR (1) | AR002385A1 (el) |
AT (1) | ATE190974T1 (el) |
AU (1) | AU700805B2 (el) |
CA (1) | CA2222132A1 (el) |
DE (1) | DE69607344T2 (el) |
DK (1) | DK0830349T3 (el) |
ES (1) | ES2145452T3 (el) |
GR (1) | GR3033199T3 (el) |
HR (1) | HRP960258B1 (el) |
IL (1) | IL122457A0 (el) |
MX (1) | MX9709125A (el) |
MY (1) | MY113863A (el) |
NZ (1) | NZ309557A (el) |
PT (1) | PT830349E (el) |
TW (1) | TW355707B (el) |
WO (1) | WO1996039393A1 (el) |
ZA (1) | ZA964749B (el) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5466797A (en) * | 1994-06-30 | 1995-11-14 | The Du Pont Merck Pharmaceutical Company | Intermediates for the preparation of cyclic urea |
US5532357A (en) * | 1995-06-07 | 1996-07-02 | The Dupont Merck Pharmaceutical Company | Method for preparing N-monosubstituted and N,N'-disubstituted unsymmetrical cyclic ureas |
US6054597A (en) * | 1995-11-14 | 2000-04-25 | Dupont Pharmaceuticals | Processes and intermediates for the preparation of cyclic urea HIV protease inhibitors |
AU6870098A (en) * | 1997-03-31 | 1998-10-22 | Du Pont Merck Pharmaceutical Company, The | Indazoles of cyclic ureas useful as hiv protease inhibitors |
US6218534B1 (en) | 1997-10-06 | 2001-04-17 | Dupont Pharmaceuticals Company | Preparation of asymmetric cyclic ureas through a monoacylated diamine intermediate |
US6313110B1 (en) * | 1999-06-02 | 2001-11-06 | Dupont Pharmaceuticals Company | Substituted 2H-1,3-diazapin-2-one useful as an HIV protease inhibitor |
WO2001092652A1 (en) * | 2000-05-30 | 2001-12-06 | Red Valve Co., Inc. | Method and apparatus for preventing stagnation in fluid reservoirs |
FR2810039B1 (fr) * | 2000-06-13 | 2007-05-25 | Centre Nat Rech Scient | Composes urees cycliques et leur procede de preparation |
EP2228369A1 (en) | 2003-12-23 | 2010-09-15 | Astex Therapeutics Ltd. | Pyrazole derivatives as protein kinase modulators |
JP2008546751A (ja) * | 2005-06-22 | 2008-12-25 | アステックス・セラピューティクス・リミテッド | 医薬組成物 |
JP5345842B2 (ja) | 2005-06-23 | 2013-11-20 | アステックス・セラピューティクス・リミテッド | プロテインキナーゼモジュレーターとしてのピラゾール誘導体を含む医薬組み合わせ |
US20080033167A1 (en) * | 2005-12-29 | 2008-02-07 | Gilles Guichard | Compositions and methods for synthesizing heterocyclic therapeutic compounds |
GB0704932D0 (en) | 2007-03-14 | 2007-04-25 | Astex Therapeutics Ltd | Pharmaceutical compounds |
KR101663255B1 (ko) * | 2015-11-30 | 2016-10-10 | 주식회사 삼양사 | 안정성이 향상된 농축 무수당 알코올 제조용 조성물 및 무수당 알코올의 농축 방법 |
KR101663264B1 (ko) * | 2015-11-30 | 2016-10-10 | 주식회사 삼양사 | 저장 안정성이 향상된 무수당 알코올 조성물 및 무수당 알코올의 저장 방법 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5610294A (en) * | 1991-10-11 | 1997-03-11 | The Du Pont Merck Pharmaceutical Company | Substituted cyclic carbonyls and derivatives thereof useful as retroviral protease inhibitors |
ATE216371T1 (de) * | 1991-10-11 | 2002-05-15 | Du Pont Pharm Co | Cyclische harnstoffe und analoga verwendbar als retrovirale proteasehemmer |
-
1995
- 1995-06-06 US US08/469,409 patent/US5532356A/en not_active Expired - Fee Related
-
1996
- 1996-06-04 JP JP9501114A patent/JPH11506765A/ja active Pending
- 1996-06-04 WO PCT/US1996/008556 patent/WO1996039393A1/en active IP Right Grant
- 1996-06-04 NZ NZ309557A patent/NZ309557A/en unknown
- 1996-06-04 IL IL12245796A patent/IL122457A0/xx unknown
- 1996-06-04 PT PT96917066T patent/PT830349E/pt unknown
- 1996-06-04 AU AU59752/96A patent/AU700805B2/en not_active Ceased
- 1996-06-04 AT AT96917066T patent/ATE190974T1/de not_active IP Right Cessation
- 1996-06-04 MX MX9709125A patent/MX9709125A/es unknown
- 1996-06-04 DE DE69607344T patent/DE69607344T2/de not_active Expired - Fee Related
- 1996-06-04 CA CA002222132A patent/CA2222132A1/en not_active Abandoned
- 1996-06-04 EP EP96917066A patent/EP0830349B1/en not_active Expired - Lifetime
- 1996-06-04 ES ES96917066T patent/ES2145452T3/es not_active Expired - Lifetime
- 1996-06-04 DK DK96917066T patent/DK0830349T3/da active
- 1996-06-06 ZA ZA9604749A patent/ZA964749B/xx unknown
- 1996-06-06 HR HR960258A patent/HRP960258B1/xx not_active IP Right Cessation
- 1996-06-06 MY MYPI96002264A patent/MY113863A/en unknown
- 1996-07-06 AR ARP960103027A patent/AR002385A1/es unknown
- 1996-07-30 TW TW085109286A patent/TW355707B/zh active
-
2000
- 2000-04-12 GR GR20000400893T patent/GR3033199T3/el not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
NZ309557A (en) | 2001-06-29 |
TW355707B (en) | 1999-04-11 |
IL122457A0 (en) | 1998-06-15 |
WO1996039393A1 (en) | 1996-12-12 |
US5532356A (en) | 1996-07-02 |
HRP960258B1 (en) | 2000-12-31 |
JPH11506765A (ja) | 1999-06-15 |
HRP960258A2 (en) | 1997-12-31 |
AU700805B2 (en) | 1999-01-14 |
ATE190974T1 (de) | 2000-04-15 |
AU5975296A (en) | 1996-12-24 |
EP0830349B1 (en) | 2000-03-22 |
DE69607344T2 (de) | 2000-09-21 |
DE69607344D1 (de) | 2000-04-27 |
EP0830349A1 (en) | 1998-03-25 |
MX9709125A (es) | 1998-03-31 |
CA2222132A1 (en) | 1996-12-12 |
AR002385A1 (es) | 1998-03-11 |
ES2145452T3 (es) | 2000-07-01 |
PT830349E (pt) | 2000-08-31 |
ZA964749B (en) | 1997-12-08 |
MY113863A (en) | 2002-06-29 |
DK0830349T3 (da) | 2000-07-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUP9600549A3 (en) | N-(3-benzofuranyl)urea-derivatives, medicaments containing the same and process for producing them | |
HUP9802978A3 (en) | Method for preparing 1,1,1,3,3-pentafluoropropane | |
GR3033199T3 (en) | Method for preparing n, n'-disubstitued cyclic ureas | |
IL117726A (en) | Process for preparing 1,1'-¬1,4-phenylenebis-(methylene)-bis-1,4,8,11,tetraazacyclo-tetradecane | |
HK1012636A1 (en) | Process for preparing cyclic polysiloxanes | |
HUP0002105A3 (en) | Method for preparing 1,1,1,3,3-pentachlorobutane | |
AU647808B2 (en) | Method for preparing cyclic sulphates | |
ZA958161B (en) | Process for preparing 1,3-alkanediols and 3-hydroxyaldehydes | |
HUP9602332A3 (en) | Method of preparing 4,6-dichloro pyrimide | |
EP1023250A4 (en) | METHOD FOR PRODUCING 2,6-DIALKYLNAPHTHALINE | |
ZA964847B (en) | Method for preparing N-monosubstituted and N,N'-disubstituted unsymmetrical cyclic ureas. | |
ZA958160B (en) | Process for preparing 1,3-alkanediols and 3-hydroxyaldehydes | |
HUP9900377A3 (en) | Novel process for preparing 2,3-dihydro-benzofuranol derivatives | |
IL95980A0 (en) | Process for preparing n,n'-bistetrabromophthalimide) | |
EP0453948A3 (en) | Method for producing 1,4-butanediol | |
HUP0003325A3 (en) | Method for producing n-alkyl-n'-nitroguanidines | |
HU9600659D0 (en) | Process for preparing cyclic cis-1-amino-2-alkanols | |
EP0751111A3 (de) | Verfahren zur Herstellung von 2,2-Dialkylaryliden-cycloalkanonen | |
GR3033873T3 (en) | Method for preparing streptogramines | |
HUP9901426A3 (en) | Method for preparing alpha, omega-bromochloroalkanes | |
GB2287937B (en) | Method for producing 3,4-dihydroxyphthalic acid | |
SG50845A1 (en) | Process for the preparation of [(5,6-dicarboxy-3-pyridyl)methyl] ammonium halides | |
HRP960328B1 (en) | METHOD FOR PREPARING "alpha", "omega" - BROMOCHLOROALCANES | |
GB2302871B (en) | Process for preparing 1,1-dioxo-cephem-4-ketones | |
HUT64537A (en) | Method for producing 1,2,3,9-tetrahydro-9-methyl-3-/(2-methyl-1h-imidazole-1-yl)methyl/-4h-carbazole-4-one |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ML | Lapse due to non-payment of fees |